Edition:
United States

Innovate Biopharmaceuticals Inc (INNT.OQ)

INNT.OQ on NASDAQ Stock Exchange Capital Market

19.82USD
4:00pm EDT
Change (% chg)

$0.34 (+1.75%)
Prev Close
$19.48
Open
$18.89
Day's High
$20.10
Day's Low
$17.82
Volume
34,566
Avg. Vol
59,489
52-wk High
$50.50
52-wk Low
$3.43

Chart for

About

Innovate Biopharmaceuticals, Inc., formerly Monster Digital, Inc., is a clinical stage biotechnology company. The Company is focused on developing novel autoimmune and inflammation therapeutic drugs. Its lead drug candidate, larazotide acetate (INN-202) is a tight junction regulator. Its other products include INN-108 and... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $5.77
Shares Outstanding(Mil.): 9.34
Dividend: --
Yield (%): --

Financials

  INNT.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -0.90 -- --
ROI: -- 1.58 14.38
ROE: -- 2.41 16.07

BRIEF-Innovate Biopharma Files For Mixed Shelf Of Up To $175 Mln

* INNOVATE BIOPHARMACEUTICALS INC FILES FOR MIXED SHELF OF UP TO $175.0 MILLION - SEC FILING

Mar 15 2018

BRIEF-Innovate Appoints June Almenoff As COO, Chief Medical Officer

* INNOVATE BIOPHARMACEUTICALS APPOINTS JUNE ALMENOFF, M.D., PH.D. AS CHIEF OPERATING OFFICER AND CHIEF MEDICAL OFFICER Source text for Eikon: Further company coverage:

Mar 13 2018

Earnings vs. Estimates

No consensus analysis data available.